AFP and liver cancer: In multivariate analyses (Table 3), female gender, diabetes, higher HCC-nonB ratios, smaller tumors, and levels closer to normal for glutamate transpeptidase and total bilirubin remained significantly associated with negative AFP and PIVKA-II in liver cancer (P < .05 for each).